Stada to acquire Takeda OTC portfolio for USD660 mn

5 November 2019 - Deborah Wilkes

Premium

Stada Arzneimittel is acquiring Takeda’s OTC portfolio in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million. The deal comes a day after the German company announced it was purchasing Czech consumer healthcare firm Walmark.

Click tags below for more information on topics:

Stada

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: